Shares of Spire Healthcare Group plc (LON:SPI - Get Free Report) crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 221.22 ($2.97) and traded as high as GBX 249.50 ($3.35). Spire Healthcare Group shares last traded at GBX 248.50 ($3.34), with a volume of 622,731 shares trading hands.
Analyst Upgrades and Downgrades
SPI has been the topic of several research reports. Berenberg Bank reissued a "buy" rating and set a GBX 280 price objective on shares of Spire Healthcare Group in a report on Thursday, July 31st. JPMorgan Chase & Co. cut their price objective on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a report on Tuesday, August 5th. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Spire Healthcare Group currently has a consensus rating of "Buy" and an average price target of GBX 294.33.
View Our Latest Report on SPI
Spire Healthcare Group Stock Down 0.2%
The company's 50 day moving average price is GBX 221.22 and its 200 day moving average price is GBX 206.44. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25. The firm has a market capitalization of £997.88 million, a price-to-earnings ratio of 5,391.30, a P/E/G ratio of 1.06 and a beta of 0.96.
Spire Healthcare Group (LON:SPI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. As a group, research analysts forecast that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current fiscal year.
Spire Healthcare Group Company Profile
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.